Organ-on-a-chip, Organoids, but Drug Testing on Whole Organs? This Startup is Betting On It

Many startups and established companies focused on drug testing on human data in preclinical studies have been boosted by FDA’s move away from reliance on animal testing towards organoid, organ-on-a-chip, and other in silico technologies. A Connecticut startup believes whole-organ testing should be an essential part of this mix. The post Organ-on-a-chip, Organoids, but Drug…

Read More

Why the Future of IDR Depends on Smarter Technology

Focusing on fringe cases of abuse misses a more immediate and arguably more pervasive problem: many provider organizations are not getting the access to IDR they’re entitled to because the process is too difficult to navigate effectively at scale.  The post Why the Future of IDR Depends on Smarter Technology appeared first on MedCity News.

Read More